Global Therapeutic Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201010288 | Category: Pharma & Healthcare | Pages: 90 | Format: PDF | Published Date: October 27,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Therapeutic Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Therapeutic Vaccines market size is estimated to be worth US$ 31940 million in 2021 and is forecast to a readjusted size of USD 112360 million by 2028 with a CAGR of 19.7% during review period. Oncotherapy accounting for % of the Therapeutic Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Peptide Therapeutic Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Therapeutic Vaccines include Northeast Biotherapeutics, Agenus, Vaccinogen Inc, CIMAB S.A, and Dendreon, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Therapeutic Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Peptide Therapeutic Vaccine
    Cell Therapeutic Vaccine
    Nucleic Acid Therapeutic Vaccine
Market segment by Application can be divided into
    Oncotherapy
    Hepatitis B
    Tuberculosis
    Herpes Simplex Virus
    Others
The key market players for global Therapeutic Vaccines market are listed below:
    Northeast Biotherapeutics
    Agenus
    Vaccinogen Inc
    CIMAB S.A
    Dendreon
    Corixa
    AVAX Technologies
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Vaccines, with price, sales, revenue and global market share of Therapeutic Vaccines from 2019 to 2022.
Chapter 3, the Therapeutic Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Therapeutic Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Vaccines.
Chapter 13, 14, and 15, to describe Therapeutic Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Therapeutic Vaccines Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Therapeutic Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Peptide Therapeutic Vaccine
        1.2.3 Cell Therapeutic Vaccine
        1.2.4 Nucleic Acid Therapeutic Vaccine
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Therapeutic Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Oncotherapy
        1.3.3 Hepatitis B
        1.3.4 Tuberculosis
        1.3.5 Herpes Simplex Virus
        1.3.6 Others
    1.4 Global Therapeutic Vaccines Market Size & Forecast
        1.4.1 Global Therapeutic Vaccines Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Therapeutic Vaccines Sales in Volume (2017-2028)
        1.4.3 Global Therapeutic Vaccines Price (2017-2028) 
    1.5 Global Therapeutic Vaccines Production Capacity Analysis
        1.5.1 Global Therapeutic Vaccines Total Production Capacity (2017-2028)
        1.5.2 Global Therapeutic Vaccines Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Therapeutic Vaccines Market Drivers
        1.6.2 Therapeutic Vaccines Market Restraints
        1.6.3 Therapeutic Vaccines Trends Analysis
2 Manufacturers Profiles
    2.1 Northeast Biotherapeutics
        2.1.1 Northeast Biotherapeutics Details
        2.1.2 Northeast Biotherapeutics Major Business
        2.1.3 Northeast Biotherapeutics Therapeutic Vaccines Product and Services
        2.1.4 Northeast Biotherapeutics Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Agenus
        2.2.1 Agenus Details
        2.2.2 Agenus Major Business
        2.2.3 Agenus Therapeutic Vaccines Product and Services
        2.2.4 Agenus Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Vaccinogen Inc
        2.3.1 Vaccinogen Inc Details
        2.3.2 Vaccinogen Inc Major Business
        2.3.3 Vaccinogen Inc Therapeutic Vaccines Product and Services
        2.3.4 Vaccinogen Inc Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 CIMAB S.A
        2.4.1 CIMAB S.A Details
        2.4.2 CIMAB S.A Major Business
        2.4.3 CIMAB S.A Therapeutic Vaccines Product and Services
        2.4.4 CIMAB S.A Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Dendreon
        2.5.1 Dendreon Details
        2.5.2 Dendreon Major Business
        2.5.3 Dendreon Therapeutic Vaccines Product and Services
        2.5.4 Dendreon Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Corixa
        2.6.1 Corixa Details
        2.6.2 Corixa Major Business
        2.6.3 Corixa Therapeutic Vaccines Product and Services
        2.6.4 Corixa Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 AVAX Technologies
        2.7.1 AVAX Technologies Details
        2.7.2 AVAX Technologies Major Business
        2.7.3 AVAX Technologies Therapeutic Vaccines Product and Services
        2.7.4 AVAX Technologies Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Therapeutic Vaccines Breakdown Data by Manufacturer
    3.1 Global Therapeutic Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Therapeutic Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Therapeutic Vaccines
    3.4 Market Concentration Rate
        3.4.1 Top 3 Therapeutic Vaccines Manufacturer Market Share in 2021
        3.4.2 Top 6 Therapeutic Vaccines Manufacturer Market Share in 2021
    3.5 Global Therapeutic Vaccines Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Therapeutic Vaccines Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Therapeutic Vaccines Market Size by Region
        4.1.1 Global Therapeutic Vaccines Sales in Volume by Region (2017-2028)
        4.1.2 Global Therapeutic Vaccines Revenue by Region (2017-2028)
    4.2 North America Therapeutic Vaccines Revenue (2017-2028)
    4.3 Europe Therapeutic Vaccines Revenue (2017-2028)
    4.4 Asia-Pacific Therapeutic Vaccines Revenue (2017-2028)
    4.5 South America Therapeutic Vaccines Revenue (2017-2028)
    4.6 Middle East and Africa Therapeutic Vaccines Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Therapeutic Vaccines Sales in Volume by Type (2017-2028)
    5.2 Global Therapeutic Vaccines Revenue by Type (2017-2028)
    5.3 Global Therapeutic Vaccines Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Therapeutic Vaccines Sales in Volume by Application (2017-2028)
    6.2 Global Therapeutic Vaccines Revenue by Application (2017-2028)
    6.3 Global Therapeutic Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Therapeutic Vaccines Sales by Type (2017-2028)
    7.2 North America Therapeutic Vaccines Sales by Application (2017-2028)
    7.3 North America Therapeutic Vaccines Market Size by Country
        7.3.1 North America Therapeutic Vaccines Sales in Volume by Country (2017-2028)
        7.3.2 North America Therapeutic Vaccines Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Therapeutic Vaccines Sales by Type (2017-2028)
    8.2 Europe Therapeutic Vaccines Sales by Application (2017-2028)
    8.3 Europe Therapeutic Vaccines Market Size by Country
        8.3.1 Europe Therapeutic Vaccines Sales in Volume by Country (2017-2028)
        8.3.2 Europe Therapeutic Vaccines Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Therapeutic Vaccines Sales by Type (2017-2028)
    9.2 Asia-Pacific Therapeutic Vaccines Sales by Application (2017-2028)
    9.3 Asia-Pacific Therapeutic Vaccines Market Size by Region
        9.3.1 Asia-Pacific Therapeutic Vaccines Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Therapeutic Vaccines Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Therapeutic Vaccines Sales by Type (2017-2028)
    10.2 South America Therapeutic Vaccines Sales by Application (2017-2028)
    10.3 South America Therapeutic Vaccines Market Size by Country
        10.3.1 South America Therapeutic Vaccines Sales in Volume by Country (2017-2028)
        10.3.2 South America Therapeutic Vaccines Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Therapeutic Vaccines Sales by Type (2017-2028)
    11.2 Middle East & Africa Therapeutic Vaccines Sales by Application (2017-2028)
    11.3 Middle East & Africa Therapeutic Vaccines Market Size by Country
        11.3.1 Middle East & Africa Therapeutic Vaccines Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Therapeutic Vaccines Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Therapeutic Vaccines and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Therapeutic Vaccines
    12.3 Therapeutic Vaccines Production Process
    12.4 Therapeutic Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Therapeutic Vaccines Typical Distributors
    13.3 Therapeutic Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Therapeutic Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?